Masso Torrence Wealth Management Inc. Abb Vie Inc. Transaction History
Masso Torrence Wealth Management Inc.
- $173 Million
- Q2 2024
A detailed history of Masso Torrence Wealth Management Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Masso Torrence Wealth Management Inc. holds 9,916 shares of ABBV stock, worth $1.93 Million. This represents 0.98% of its overall portfolio holdings.
Number of Shares
9,916
Previous 10,247
3.23%
Holding current value
$1.93 Million
Previous $1.87 Million
8.85%
% of portfolio
0.98%
Previous 1.16%
Shares
11 transactions
Others Institutions Holding ABBV
# of Institutions
3,697Shares Held
1.27BCall Options Held
13MPut Options Held
9.79M-
Vanguard Group Inc Valley Forge, PA171MShares$33.2 Billion0.57% of portfolio
-
Black Rock Inc. New York, NY136MShares$26.5 Billion0.54% of portfolio
-
State Street Corp Boston, MA77.8MShares$15.1 Billion0.59% of portfolio
-
Jpmorgan Chase & CO New York, NY53.6MShares$10.4 Billion0.81% of portfolio
-
Capital International Investors Los Angeles, CA38.6MShares$7.5 Billion1.4% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $344B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...